Director Appointment and Nomination Agreement under which the Board was increased to thirteen directors, the Icahn Designees were appointed to the Board and its committees and nominated for election; terminated August 14, 2025
| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Thomas J. Appio
Also a director
Chief Executive Officer
|
64 | Not stated | Not stated | $16,877,326 | |
|
Jean-Jacques Charhon
Executive Vice President, Chief Financial Officer
|
60 | Not stated | 2024 | Not reported | |
|
Seana Carson
Executive Vice President, General Counsel
|
54 |
Since 2022
4 years
|
2006 | Not reported | |
|
Steven Hyosig Lee
SVP, Controller & CAO
Title from the Form 4 dated Jul 14, 2026
|
Not stated | Not stated | Not stated | Not reported | |
|
Aimee J. Lenar
Executive Vice President, US Pharma
|
50 |
Since 2024
2 years
|
2024 | $3,264,491 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 8, 2026 · updated by the 8-K of Jul 1, 2026
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Director Appointment and Nomination Agreement under which the Board was increased to thirteen directors, the Icahn Designees were appointed to the Board and its committees and nominated for election; terminated August 14, 2025
Loading...